SCHEMBL1128560

SCHEMBL1128560

CCCCc1ccccc1B(O)O

nearest known ligand 0.85

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.85
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
PCSK9 Q8NBP7 1/20 0.44
LPL P06858 6/20 0.42
TYR P14679 1/20 0.42
TRPV1 Q8NER1 1/20 0.41
MGLL Q99685 1/20 0.41
ALOX5 P09917 1/20 0.41
PTGS2 P35354 1/20 0.41
TLR8 Q9NR97 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29948801 1.00 LIPG (0.85) LIPGCA1CA2CYP3A4CYP2D6
SCHEMBL747937 0.94 LIPG (0.96) LIPGLPLTRPV1MGLLALOX5
SCHEMBL29670235 0.94 LIPG (0.96) LIPGLPLTRPV1MGLLALOX5
SCHEMBL31403378 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1
SCHEMBL31591938 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1
SCHEMBL6153283 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1
SCHEMBL4449189 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1
Methyl Alcohol SCHEMBL28643289 0.92 LIPG (0.92) LIPGLPLTRPV1MGLLALOX5
SCHEMBL435360 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1
SCHEMBL11415024 0.92 LIPG (1.00) LIPGCYP3A4LPLTYRTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12402638-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-09-02 US disclosed
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US disclosed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US disclosed
CN-119708891-A Organic silicon oligomer intercalated montmorillonite, preparation method thereof, modified hot melt boron phenolic resin and preparation method thereof 西安交通大学 2025-03-28 CN disclosed
US-12232516-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-02-25 US disclosed
CN-113677731-B Graphene nanoribbon and preparation method thereof 田冈化学工业株式会社 2025-02-07 CN disclosed
US-12193465-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-01-14 US disclosed
CN-119264347-A Degradable flame-retardant phenolic aerogel and preparation method and application thereof 中车成型科技(青岛)有限公司 2025-01-07 CN disclosed
CN-117903387-A Low-free aldehyde hot-melt boron phenolic resin and preparation method thereof 西安交通大学 2024-04-19 CN disclosed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
EP-1448578-A1 METALLOCENE COMPOUNDS AND PROCESS FOR THE PREPARATION OF PROPYLENE POLYMERS Basell Polyolefine GmbH (DE) 2004-08-25 EP disclosed
WO-2004054515-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2004-07-01 WO disclosed
WO-2003045964-A1 METALLOCENE COMPOUNDS AND PROCESS FOR THE PREPARATION OF PROPYLENE POLYMERS BASELL POLYOLEFINE GMBH (DE) 2003-06-05 WO disclosed
US-20030083361-A1 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia SMITHKLINE BEECHAM CORPORATION 2003-05-01 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
EP-1244446-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-01-08 EP disclosed
EP-1244446-A1 THROMBOPOIETIN MIMETICS SmithKline Beecham Corporation (US) 2002-10-02 EP disclosed
WO-2001039773-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-06-07 WO disclosed
US-6103743-A Unsaturated amino acid derivatives ALLELIX NEUROSCIENCE, INC. (US) 2000-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083361-A1 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia MPL, THPO, TPO LIPG 1370/4885CA1 4794/4885CA2 4526/4885
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A LIPG 4401/4885CA1 3547/4885CA2 4329/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 LIPG 4535/4885CA1 3105/4885CA2 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.